CSPC Pharmaceutical Group Limited CSPCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.71B | 1.50B | 1.48B | 1.36B | 1.35B |
| Total Receivables | 1.31B | -- | 1.26B | -- | 1.38B |
| Inventory | 472.52M | -- | 441.89M | -- | 426.31M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 43.70M | -- | -- | -- | -- |
| Total Current Assets | 4.54B | -- | 3.18B | -- | 3.16B |
|
|
|||||
| Total Current Assets | 4.54B | -- | 3.18B | -- | 3.16B |
| Net Property, Plant & Equipment | 2.01B | -- | 1.93B | -- | 1.82B |
| Long-term Investments | 34.75M | -- | 33.58M | -- | 32.79M |
| Goodwill | 34.75M | -- | 33.58M | -- | 32.79M |
| Total Other Intangibles | 439.48M | -- | 380.01M | -- | 370.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 119.89M | -- | 136.75M | -- | 122.02M |
| Total Assets | 8.25B | -- | 6.68B | -- | 6.42B |
|
|
|||||
| Total Accounts Payable | 441.54M | -- | 487.38M | -- | 376.15M |
| Total Accrued Expenses | 623.92M | -- | 516.60M | -- | -- |
| Short-term Debt | 18.97M | -- | 44.00M | -- | 27.70M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.82M | -- | 21.83M | -- | 19.23M |
| Total Finance Division Other Current Liabilities | 1.02B | -- | 385.33M | -- | 988.53M |
| Total Other Current Liabilities | 1.02B | -- | 385.33M | -- | 988.53M |
| Total Current Liabilities | 2.12B | -- | 1.46B | -- | 1.41B |
|
|
|||||
| Total Current Liabilities | 2.12B | -- | 1.46B | -- | 1.41B |
| Long-Term Debt | 40.40M | -- | -- | -- | -- |
| Short-term Debt | 18.97M | -- | 44.00M | -- | 27.70M |
| Capital Leases | 16.87M | -- | 25.83M | -- | 22.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 261.63M | -- | 255.81M | -- | 121.06M |
| Total Liabilities | 2.44B | -- | 1.74B | -- | 1.55B |
|
|
|||||
| Common Stock & APIC | 1.71B | -- | 1.65B | -- | 1.61B |
| Retained Earnings | 4.64B | -- | 3.84B | -- | 3.74B |
| Treasury Stock & Other | -804.12M | -- | -752.81M | -- | -714.73M |
| Total Common Equity | 5.54B | 4.81B | 4.74B | 4.67B | 4.64B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.54B | 4.81B | 4.74B | 4.67B | 4.64B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 266.04M | -- | 196.15M | -- | 225.33M |
| Total Equity | 5.80B | 5.01B | 4.94B | 4.90B | 4.87B |
|
|
|||||